Finance
AstraZeneca 'magic' faces rare test after trial failure, share slide
By Maggie Fick LONDON, July 24 (Reuters) - AstraZeneca's long-time CEO Pascal Soriot has rarely put...
24th July, 2026
Pharmaceuticals
Latest articles
Finance
Generic drugmaker Sandoz to engage with US after Trump tariff threat
By Marleen Kaesebier ZURICH, July 22 (Reuters) - Swiss generic drugmaker Sandoz said on Wednesday it...
22nd July, 2026
Finance
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
By Maggie Fick LONDON, July 21 (Reuters) - Novo Nordisk said on Tuesday it was suing rival Eli Lilly...
21st July, 2026
Finance
Novartis backs full year forecast after $6 billion profit beat helped by one-offs
July 21 - Novartis' second-quarter core operating profit beat market expectations on Tuesday, helped...
21st July, 2026
Finance
Novartis faces drug pipeline test with valuation premium in focus
By Bhanvi Satija LONDON, July 20 (Reuters) - Novartis investors will look beyond Tuesday's quarterly...
20th July, 2026
Finance
Samsung Biologics to launch $1.8 billion all-cash bid for PolyPeptide
July 20 (Reuters) - South Korea's Samsung Biologics will launch a 1.46 billion Swiss francs ($1.81 b...
20th July, 2026
Finance
Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent
July 15 (Reuters) - Recordati said on Wednesday that a majority of its board has deemed as "fair" an...
15th July, 2026
Finance
Alector and GSK partnership to end after dementia, Alzheimer's drug failures
July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboratio...
8th July, 2026
Finance
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
July 8 (Reuters) - Drugmakers AstraZeneca and Daiichi Sankyo are nearing an agreement with the UK's...
8th July, 2026
Finance
Swiss pharma at risk of US trade investigation, industry body says
ZURICH, June 26 (Reuters) - The United States could open a trade investigation into Switzerland's ph...
26th June, 2026
Finance
EU regulator backs revoking Amgen's right to sell rare-disease drug
By Christy Santhosh June 26 (Reuters) - Europe's drug regulator on Friday recommended revoking the m...
26th June, 2026
Finance
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says
By Maggie Fick and Andrew Silver BRUSSELS, June 24 (Reuters) - Eli Lilly's orforglipron type-2 diabe...
24th June, 2026